Uni-Bio Science Group's revenue for the
six
months ended in Dec. 2023 was HK$234.8 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$484.7 Mil.
Uni-Bio Science Group's Revenue per Share for the
six
months ended in Dec. 2023 was HK$0.04.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.08.
Warning Sign:
Uni-Bio Science Group Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Uni-Bio Science Group was 10.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 32.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 29.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Uni-Bio Science Group's highest 3-Year average Revenue per Share Growth Rate was 35.70% per year. The lowest was -62.50% per year. And the median was -10.90% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Uni-Bio Science Group's Revenue
For the Biotechnology subindustry, Uni-Bio Science Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uni-Bio Science Group's Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's Revenue distribution charts can be found below:
* The bar in red indicates where Uni-Bio Science Group's Revenue falls into.
Uni-Bio Science Group Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$484.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uni-Bio Science Group (HKSE:00690) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Uni-Bio Science Group Revenue Related Terms
Thank you for viewing the detailed overview of Uni-Bio Science Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Uni-Bio Science Group (HKSE:00690) Business Description
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00690 has been successfully added to your 